What is the role of Peyer patches in the immune system and their significance in clinical medicine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peyer's Patches: Role in the Immune System and Clinical Significance

Peyer's patches are specialized lymphoid structures in the intestinal wall that serve as critical surveillance sites for the gut immune system, playing essential roles in mucosal immunity, antigen sampling, and immune response initiation.

Anatomical Distribution and Structure

  • Peyer's patches are concentrated in the distal ileum, with approximately 46% of patch tissue occurring in the terminal 25 cm of the small intestine 1
  • They form a lymphoid ring in the terminal 10-15 cm of the ileum, while more proximal patches are oval-shaped, located on the antimesenteric border, and irregularly spaced 1
  • The number of patches varies with age, ranging from approximately 29 in younger individuals to 19 in older individuals 1
  • Peyer's patches are non-encapsulated lymphoid tissues consisting of highly organized ovoid-shaped follicles 2

Cellular Composition and Organization

  • Peyer's patches are populated with multiple immune cell types:
    • B cells (predominant in follicles)
    • T cells
    • Macrophages
    • Dendritic cells 2, 3
  • They contain specialized structures:
    • Follicle-associated epithelium (FAE) with M cells that facilitate antigen sampling
    • Subepithelial dome (SED) rich in mononuclear phagocytes
    • Germinal centers where B cells proliferate and differentiate 3

Immunological Functions

  1. Antigen Sampling and Surveillance

    • M cells in the follicle-associated epithelium facilitate transcytosis of antigens from the intestinal lumen 3
    • This provides continuous monitoring of gut contents, including potential pathogens and commensal microbiota
  2. Immune Response Initiation

    • Mononuclear phagocytes in the subepithelial dome capture antigens and present them to T cells 3
    • This initiates appropriate immune responses against pathogens while maintaining tolerance to food antigens and commensals
  3. Mucosal Immunity Development

    • Peyer's patches are critical for the development of gut-associated lymphoid tissue (GALT) 4
    • They contribute to the production of secretory IgA, which provides the first line of defense at mucosal surfaces
  4. Immune Cell Education

    • Peyer's patches help educate immune cells about gut antigens, promoting appropriate responses to pathogens while preventing harmful reactions to beneficial microbes

Regional Heterogeneity

  • Peyer's patches show significant regional differences in gene expression patterns between duodenum, jejunum, and ileum 2
  • Approximately 18.5% of highly expressed genes differ significantly between duodenal and ileal Peyer's patches 2
  • These differences involve structural, metabolic, and immune-related genes:
    • Duodenal Peyer's patches: Lower expression of complement C3d receptor, lymphocyte cytosolic protein 1, and lysozyme C2 precursor
    • Ileal Peyer's patches: Lower expression of alcohol dehydrogenase 1, gap junction protein beta 2, and serine peptidase inhibitor 2

Clinical Significance

1. Inflammatory Bowel Disease

  • Peyer's patches may play a role in the extension of ulcerative colitis into the terminal ileum 5
  • Abnormalities in the follicle-associated epithelium on Peyer's patch domes and surrounding villi are common in UC patients, similar to findings in Crohn's disease 5
  • These abnormalities can be reversible following remission with appropriate therapy 5

2. Pathogen Entry Sites

  • Peyer's patches can serve as entry portals for intestinal pathogens 3
  • Various microorganisms have evolved strategies to exploit this gateway to enter the host and disseminate 3
  • Understanding these mechanisms is crucial for developing mucosal-based therapeutic approaches

3. Immune Development

  • Intestinal arginine synthesis during early development is important for the normal development of Peyer's patches 4
  • Arginine deficiency can lead to impaired development of gut-associated lymphoid tissue, with Peyer's patches failing to develop until adulthood 4

4. Diagnostic Applications

  • Magnifying endoscopy can be used to evaluate Peyer's patches in the terminal ileum, potentially aiding in the diagnosis and monitoring of inflammatory bowel disease 5

Factors Affecting Peyer's Patch Development and Function

  1. Age

    • The number and total area of Peyer's patches vary with age
    • Peak total patch area occurs in young adults (21-30 years) 1
  2. Nutritional Factors

    • Arginine deficiency can impair Peyer's patch development 4
    • Nutritional status may influence immune function within these structures
  3. Microbiota

    • Interaction with the intestinal microbiota shapes Peyer's patch development and function 3
    • The microbiome acts as an intermediary between the organism and its environment 6

Clinical Implications and Future Directions

  • Understanding Peyer's patch function may lead to improved mucosal vaccine strategies
  • Targeting specific mononuclear phagocyte subsets within Peyer's patches could enhance immune responses or treat intestinal inflammatory conditions
  • Further research into the regional heterogeneity of Peyer's patches may reveal specialized functions related to their location in the intestine
  • Developing methods to modulate Peyer's patch function could potentially treat inflammatory bowel disease and other intestinal disorders

References

Research

Distribution of Peyer's patches in the distal ileum.

Inflammatory bowel diseases, 2002

Research

Regional heterogeneity in rat Peyer's patches through whole transcriptome analysis.

Experimental biology and medicine (Maywood, N.J.), 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Skin Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.